市場調査レポート

商品コード

1619017

心臓モニタリング・心調律管理デバイスの世界市場規模、シェア、成長分析：心臓モニタリングデバイスタイプ別、心調律管理デバイスタイプ別、処置別、用途別、エンドユーザー別、地域別 - 産業予測（2024年～2031年）

Cardiac Monitoring and Cardiac Rhythm Management Devices Market Size, Share, Growth Analysis, By Cardiac Monitoring Devices Type, By Cardiac Rhythm Management Devices Type, By Procedure, By Application, By End User, By Region- Industry Forecast 2024-2031

出版日: 2024年12月18日
発行: SkyQuest
ページ情報: 英文 242 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 763,783円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 893,482円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,023,181円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.11円

全表示
概要
目次

概要

サンプル依頼リストに入れる

心臓モニタリング・心調律管理デバイスの世界市場規模は、2022年に212億米ドルと評価され、2023年の221億5,000万米ドルから2031年には315億1,000万米ドルに成長し、予測期間中（2024年～2031年）のCAGRは4.5％で成長する見通しです。

心調律管理・モニタリングデバイス市場は、心不全、心房細動、遺伝性疾患など、一貫したモニタリングと管理を必要とする疾患の有病率の増加により、大きな成長を遂げています。この拡大には、先進地域と開発途上地域の両方におけるアンメット・メディカル・ニーズの高まり、ライフスタイルの変化、技術の進歩が拍車をかけています。心臓疾患に対する意識の高まり、充実したヘルスケアプログラム、MRI対応デバイス導入などの要因が、市場力学をさらに高めています。しかし、高齢化、高血圧や糖尿病などの生活習慣病、社会経済的な多様性といったリスク要因がもたらす課題にも直面しています。また、アジア太平洋の経済成長は、今後数年間の市場開拓の大きな起爆剤になると期待されています。

市場概要
除細動器
- 埋め込み型除細動器
経静脈ICDS
皮下ICDS
- 体外式除細動器
- 自動体外式除細動器
- 手動体外式除細動器
- ウェアラブル除細動器
ペースメーカー
- 埋め込み性別
- 埋め込み型ペースメーカー
- 体外ペースメーカー
- タイプ別
両心室/CRT-PS
- デュアルチャンバーペースメーカー
- シングルチャンバーペースメーカー

心臓モニタリング・心調律管理デバイス市場規模：処置別、CAGR（2024年～2031年）

市場概要
侵襲的処置
非侵襲的処置

心臓モニタリング・心調律管理デバイス市場規模：用途別、CAGR（2024年～2031年）

市場概要
不整脈
心筋梗塞
心不全
その他の用途

心臓モニタリング・心調律管理デバイス市場規模：エンドユーザー別、CAGR（2024年～2031年）

市場概要
病院
クリニック
心臓センター
外来手術センター
その他のエンドユーザー

心臓モニタリング・心調律管理デバイス市場規模、CAGR（2024年～2031年）

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州
アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2023年）
主な市場企業が採用した戦略
市場の最近の動向
企業の市場シェア分析（2023年）
主要企業プロファイル
- 会社概要
- 製品ポートフォリオ分析
- セグメント別シェア分析
- 収益の前年比の比較（2021年～2023年）

主要企業プロファイル

Biotronik SE & Co. KG
Medtronic
Boston Scientific
Abbott Laboratories
GE Healthcare
Philips Healthcare
Nihon Kohden
Schiller
Edwards Lifesciences
Spacelabs Healthcare
OSI Systems
Mindray Medical
Fukuda Denshi
Innomed Medical
Biotronik
Progetti Srl
Zoll Medical Corporation
LivaNova Plc
Osypka ag
Alivecor, inc.

結論と推奨事項

Product Code: SQMIG35A2212

Global Cardiac Monitoring and Cardiac Rhythm Management Devices Market size was valued at USD 21.2 billion in 2022 and is poised to grow from USD 22.15 billion in 2023 to USD 31.51 billion by 2031, growing at a CAGR of 4.5% during the forecast period (2024-2031).

The cardiac rhythm management and monitoring device market is experiencing significant growth driven by the increasing prevalence of conditions such as heart failure, atrial fibrillation, and genetic disorders, which require consistent monitoring and management. This expansion is fueled by rising unmet medical needs across both developed and developing regions, lifestyle changes, and advancements in technology. Factors like heightened awareness of cardiac disorders, robust healthcare programs, and the introduction of MRI-compatible devices are further enhancing market dynamics. However, the market also faces challenges presented by risk factors such as aging populations, lifestyle diseases like hypertension and diabetes, and socio-economic diversity. The Asia-Pacific region's economic growth is expected to be a major catalyst for market development in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cardiac Monitoring and Cardiac Rhythm Management Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cardiac Monitoring and Cardiac Rhythm Management Devices Market Segmental Analysis

Global Cardiac Monitoring and Cardiac Rhythm Management Devices Market is segmented by cardiac monitoring devices type, cardiac rhythm management devices type, procedure, application, end user and region. Based on cardiac monitoring devices type, the market is segmented into ECG devices, MCT devices and com devices. Based on cardiac rhythm management devices type, the market is segmented into defibrillators and pacemakers. Based on procedure, the market is segmented into invasive procedures and non-invasive procedures. Based on application, the market is segmented into arrhythmias, myocardial infarction, heart failure and other applications. Based on end user, the market is segmented into hospitals, clinics, cardiac centers, ambulatory surgery centers and other end users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cardiac Monitoring and Cardiac Rhythm Management Devices Market

The Global Cardiac Monitoring and Cardiac Rhythm Management Devices market is significantly propelled by several key factors, notably the rising incidence of cardiovascular diseases. As these health issues become more prevalent, the demand for advanced monitoring and management devices has surged. Contributing to this growth are escalating healthcare costs associated with cardiac conditions, an increased shift towards ambulatory and home care services, favorable government policies, and ongoing technological advancements in medical devices. Innovations such as MRI-compatible pacemakers, subcutaneous implantable cardioverter defibrillators (ICDs), and Automated External Defibrillators (AEDs) are particularly impactful. In the United States, cardiovascular diseases remain a leading cause of mortality, accounting for approximately 25% of all deaths, further highlighting the need for effective monitoring and management solutions in this sector.

Restraints in the Global Cardiac Monitoring and Cardiac Rhythm Management Devices Market

The growth of the Global Cardiac Monitoring and Cardiac Rhythm Management Devices market is significantly hindered by the high costs associated with these advanced medical devices, which can be prohibitive for many potential users. Additionally, the limitations in insurance coverage further exacerbate this challenge, as patients may find it difficult to afford the necessary treatments and monitoring solutions. This combination of steep pricing and inadequate insurance support presents substantial barriers to market penetration and adoption, ultimately restricting the overall expansion of this vital sector within the healthcare industry. Addressing these economic factors is crucial for facilitating broader access to these essential devices.

Market Trends of the Global Cardiac Monitoring and Cardiac Rhythm Management Devices Market

The Global Cardiac Monitoring and Cardiac Rhythm Management Devices market is witnessing a significant upward trajectory, driven by an increasing focus on comprehensive cardiovascular care that extends beyond traditional monitoring. With the dual emphasis on restoring and improving cardiac health, advancements in technology have enhanced device functionality, facilitating real-time data analysis and proactive intervention. This evolving landscape is further bolstered by rising life expectancy and a growing prevalence of cardiovascular diseases, leading to heightened demand for innovative solutions. Collaborations among leading biotech firms are accelerating research and development, leading to the emergence of sophisticated CRM technologies that not only manage but also heal.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2023
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technological Advancement
Regulatory Landscape
Case Studies

Global Cardiac Monitoring and Cardiac Rhythm Management Devices Market Size by Cardiac Monitoring Devices Type & CAGR (2024-2031)

Market Overview
ECG Devices
Resting ECG Devices
Stress ECG Devices
- Holter Monitors
- Event Monitors
Smart ECG Monitors
Mct Devices
Com Devices

Global Cardiac Monitoring and Cardiac Rhythm Management Devices Market Size by Cardiac Rhythm Management Devices Type & CAGR (2024-2031)

Market Overview
Defibrillators
- Implantable Cardioverter Defibrillators
Transvenous ICDS
Subcutaneous ICDS
- External Defibrillators
- Automated External Defibrillators
- Manual External Defibrillators
- Wearable Cardioverter Defibrillators
Pacemakers
- By Implantability
- Implantable Pacemakers
- External Pacemakers
- By Type
Biventricular/CRT-PS
- Dual-Chamber Pacemakers
- Single-Chamber Pacemakers

Global Cardiac Monitoring and Cardiac Rhythm Management Devices Market Size by Procedure & CAGR (2024-2031)

Market Overview
Invasive Procedures
Non-Invasive Procedures

Global Cardiac Monitoring and Cardiac Rhythm Management Devices Market Size by Application & CAGR (2024-2031)

Market Overview
Arrhythmias
Myocardial Infarction
Heart Failure
Other Applications

Global Cardiac Monitoring and Cardiac Rhythm Management Devices Market Size by End User & CAGR (2024-2031)

Market Overview
Hospitals
Clinics
Cardiac Centers
Ambulatory Surgery Centers
Other End Users

Global Cardiac Monitoring and Cardiac Rhythm Management Devices Market Size & CAGR (2024-2031)

North America (Cardiac Monitoring Devices Type, Cardiac Rhythm Management Devices Type, Procedure, Application, End User)
- USA
- Canada
Europe (Cardiac Monitoring Devices Type, Cardiac Rhythm Management Devices Type, Procedure, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Cardiac Monitoring Devices Type, Cardiac Rhythm Management Devices Type, Procedure, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Cardiac Monitoring Devices Type, Cardiac Rhythm Management Devices Type, Procedure, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Cardiac Monitoring Devices Type, Cardiac Rhythm Management Devices Type, Procedure, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2023
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Biotronik SE & Co. KG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Philips Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nihon Kohden
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Schiller
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Edwards Lifesciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Spacelabs Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OSI Systems
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mindray Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fukuda Denshi
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Innomed Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biotronik
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Progetti Srl
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zoll Medical Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LivaNova Plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Osypka ag
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alivecor, inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments